Sudo Biosciences is a biopharmaceutical company committed to designing and developing novel, best-in-class medicines to transform patients’ lives.
Location: United States, California, Menlo Park
Employees: 11-50
Total raised: $300M
Founded date: 2021
Investors 1
Date | Name | Website |
- | Frazier Li... | frazierls.... |
Funding Rounds 3
Date | Series | Amount | Investors |
13.02.2024 | Series B | $147M | - |
20.12.2023 | Series B | $116M | - |
29.09.2022 | Series A | $37M | - |
Mentions in press and media 7
Date | Title | Description | Source |
13.02.2024 | Sudo Biosciences Raises Additional $30M in Series B; Brought... | Sudo Biosciences, a Carmel, IN-based biopharmaceutical company committed to designing and developing... | finsmes.co... |
13.02.2024 | Sudo Biosciences Announces Second Close of Upsized Series B ... | CARMEL, IN - Sudo Biosciences (“Sudo”), a biopharmaceutical company committed to designing and devel... | svhealthin... |
20.12.2023 | Sudo Biosciences Raises $116M Series B | CARMEL, IN, Sudo Biosciences announced the close of a $116 million Series B financing round co-led... | vcnewsdail... |
20.12.2023 | Sudo Biosciences Raises $116M in Series B Financing | Sudo Biosciences, a Carmel, IN-based biopharmaceutical company committed to designing and developing... | finsmes.co... |
29.09.2022 | Sudo Biosciences Raises $37M in Series A Financing | Sudo Biosciences, a Menlo Park, CA-based biopharmaceutical company, raised $37M in Series A funding.... | finsmes.co... |
28.09.2022 | Sudo Biosciences Scores $37M Series A | MENLO PARK, CA, Sudo Biosciences, a biopharmaceutical company, announced the close of $37M in Seri... | vcnewsdail... |
- | Sudo Biosciences | “Sudo Biosciences is a biopharmaceutical company committed to designing and developing novel, best-i... | fastfounde... |